BARCELONA — A new three-pronged approach to hepatitis C virus effectively treated prior non-responders...
Read More
BARCELONA — In this video perspective from the International Liver Congress, Fred Poordad, MD,...
– 95 percent of patients achieved SVR12 with 12 weeks of ABT-493 and ABT-530...
AbbVie (NYSE: ABBV) announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis...
This edition contains the following: Frequently Asked Questions on Liver Disease Managing HCV-infected Patients...
This edition contains the following: Grazoprevir and Elbasvir Combination Therapy Portal Vein Thrombosis New...
This edition contains the following: Grand Opening of our Austin and McAllen Clinics Updates...
http://medpagetoday.s3.amazonaws.com/media/sponsors/hothcv/Pipeline2.mp4 MedPage Today invited specialists from leading medical institutions to weigh in on the...
The U.S. Food and Drug Administration has granted amended Breakthrough Therapy Designation for an...
MedPage Today invited specialists from leading medical institutions to weigh in on the latest...